. Author manuscript; available in PMC: 2020 Aug 11.

Published in final edited form as: Gynecol Oncol. 2019 Apr 16;154(1):72–76. doi: 10.1016/j.ygyno.2019.04.011

Table 4.

Calibration estimates for the predictive model for suboptimal cytoreduction (RD >1 cm)

Total predictive value score	Total patients	Optimal	Suboptimal	Observed suboptimal rate in the Mayo validation cohort (95% CI)^*	Predicted suboptimal rate in the published model development cohort
Total predictive value score	N (%)	N	N
0	17/276 (6.2%)	16	1	5.9% (0.2–28.7%)	5%
1–2	74/276 (26.8%)	69	5	6.8% (2.2–15.1%)	10%
3–4	63/276 (22.8%)	62	1	1.6% (0.04–8.5%)	17%
5–6	55/276 (19.9%)	49	6	10.9% (4.1–22.3%)	34%
7–8	38/276 (13.8%)	30	8	21.1% (9.6–37.3%)	52%
≥9	29/276 (10.5%)	24	5	17.2% (5.9–35.8%)	74%

Exact 95% confidence intervals for a binominal proportion.